Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study.

Surial, Bernard; Ledergerber, Bruno; Calmy, Alexandra; Cavassini, Matthias; Günthard, Huldrych F; Kovari, Helen; Stöckle, Marcel; Bernasconi, Enos; Schmid, Patrick; Fux, Christoph A; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2020). Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study. Journal of infectious diseases, 222(4), pp. 637-645. Oxford University Press 10.1093/infdis/jiaa125

[img]
Preview
 Text
Surial_HIVHBV_TAF_renal_JID20epub.pdf - Accepted Version
Available under License Publisher holds Copyright.
Download (779kB) | Preview
[img] Text
Surial JInfectDis 2020.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (265kB)

BACKGROUND

Replacing tenofovir disoproxil fumarate (TDF) with tenofovir alafenamide (TAF) improves renal tubular markers in HIV-infected individuals, but the impact on estimated glomerular filtration rate (eGFR) remains unclear.

METHODS

We included all participants from the Swiss HIV Cohort Study who switched from a TDF to a TAF-containing antiretroviral regimen or continued TDF. We estimated changes in eGFR and urine protein-to-creatinine ratio (UPCR) after 18 months using mixed-effect models.

RESULTS

Of 3'520 participants (26.6% women, median age 50 years), 2'404 (68.5%) switched to TAF. Prior to switch, 1'664 (47.3%) had an eGFR <90 mL/min, and 1'087 (30.9%) a UPCR ≥15 mg/mmol. In patients with a baseline eGFR ≥90 mL/min, eGFR decreased with the use of TDF and TAF (-1.7 ml/min). Switching to TAF was associated with increases in eGFR of 1.5 mL/min (95% CI 0.5-2.5) if the baseline eGFR was 60-89 mL/min, and 4.1 mL/min (95% CI 1.6-6.6) if <60 mL/min. In contrast, eGFR decreased by 5.8 mL/min (95% CI 2.3-9.3) with the continued use of TDF in individuals with a baseline eGFR <60 mL/min. UPCR decreased after replacing TDF by TAF, independent of baseline eGFR.

CONCLUSIONS

Switching from TDF to TAF improves eGFR and proteinuria in patients with renal dysfunction.

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

 Surial, Bernard, Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles

Subjects:

 300 Social sciences, sociology & anthropology > 360 Social problems & social services
600 Technology > 610 Medicine & health

ISSN:

 0022-1899

Publisher:

 Oxford University Press

Funders:

 [4] Swiss National Science Foundation

Language:

 English

Submitter:

 Annelies Luginbühl

Date Deposited:

 07 Apr 2020 16:24

Last Modified:

 05 Dec 2022 15:37

Publisher DOI:

 10.1093/infdis/jiaa125

PubMed ID:

 32189003

Uncontrolled Keywords:

 Tenofovir alafenamide antiretroviral therapy comorbidities estimated glomerular filtration rate renal tubulopathy switch urine protein-to-creatinine ratio

BORIS DOI:

 10.7892/boris.142237

URI:

 https://boris.unibe.ch/id/eprint/142237

Actions (login required)

Edit item Edit item
Provide Feedback